$0.76
+0.02 (+2.70%)
Open$0.72
Previous Close$0.74
Day High$0.76
Day Low$0.68
52W High$4.11
52W Low$0.64
Volume—
Avg Volume16.8K
Market Cap7.93M
P/E Ratio—
EPS$-1.05
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 183.6K | 176.6K | 1.91M |
| Net Income | -7,343,191 | -6,358,964 | 328.9K |
| Profit Margin | -4,011.7% | -3,811.2% | 17.2% |
| EBITDA | -4,403,203 | -4,024,865 | 495.2K |
| Free Cash Flow | — | — | 411.8K |
| Rev Growth | +3.9% | +3.9% | -9.8% |
| Debt/Equity | 0.27 | 0.27 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |